AdamZayacMD

Hematologic Oncology

Assistant Professor of Medicine

Dr. Zayac is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 Little Albany St
East Tower 9TH floor
New Brunswick, NJ 08901
Phone+1 732-235-2465

Fax+1 732-448-7887

Dr. Adam Zayac is a hematologic oncologist in New Brunswick, NJ. He received his medical degree from the University at Buffalo School of Medicine, medical residency and chief residency at SUNY Upstate Medical University in Syracuse, NY, and hematology-oncology fellowship at The Warren Alpert Medical School of Brown University/Rhode Island Hospital in Providence, RI and has been in practice 2 years. He is board-certified in internal medicine, medical oncology, and hematology. He specializes in hematologic oncology and focuses on the treatment of myeloid malignancies, acute leukemias, myelodysplasia, myelofibrosis, and myeloproliferative neoplasms. He has more than 20 publications and over 250 citings.

Brown UniversityFellowship, Hematology and Medical Oncology, 2018 - 2021
SUNY Upstate Medical UniversityChief Residency, Internal Medicine, 2017 - 2018
SUNY Upstate Medical UniversityResidency, Internal Medicine, 2014 - 2017
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2014

PubMed

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.
Narendranath Epperla, Adam S Zayac, Daniel J Landsburg, Allison M Bock, Grzegorz S Nowakowski
Blood Advances. 2024-10-22
9 citations
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Adam S Zayac, Daniel J Landsburg, Mitchell E Hughes, Allison M Bock, Grzegorz S Nowakowski
Blood Advances. 2023-11-14
13 citations
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin
American Journal of Hematology. 2023-06-01

Abstracts/Posters

Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)
Adam Zayac, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
Adam Zayac, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019

Lectures

BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/9/2019